HOming in on arteriovenous fistula survival
- PMID: 18560362
- PMCID: PMC2645071
- DOI: 10.1038/ki.2008.127
HOming in on arteriovenous fistula survival
Abstract
Vascular access failure is a major clinical problem for patients on hemodialysis, but therapeutic approaches aimed at improving arteriovenous fistula (AVF) dysfunction remain elusive. Using a murine AVF model, Juncos et al. demonstrate for the first time that the stress protein heme oxygenase-1 (HO-1) is induced in AVFs and that HO-1 is a critical determinant of AVF survival.
Figures
Comment on
-
Genetic deficiency of heme oxygenase-1 impairs functionality and form of an arteriovenous fistula in the mouse.Kidney Int. 2008 Jul;74(1):47-51. doi: 10.1038/ki.2008.110. Epub 2008 Mar 26. Kidney Int. 2008. PMID: 18368029 Free PMC article.
References
-
- Feldman HI, Kobrin S, Wasserstein A. Hemodialysis vascular access morbidity. J Am Soc Nephrol. 1996;7:523–535. - PubMed
-
- Roy-Chaudhury P, Lee TC. Vascular stenosis: biology and interventions. Curr Opin Nephrol Hypertens. 2007;16:516–522. - PubMed
-
- Lin C-C, Yang W-C, Lin SJ, et al. Length polymorphism in heme oxygenase-1 is associated with arteriovenous fistula patency in hemodialysis patients. Kidney Int. 2006;69:165–172. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
